جست‌وجوی استاد و پژوهشگر

Tommy Voمشاهده پروفایل

استادیار

• Epigenetics
• Molecular Biology
• Genetics
• +۳ مورد دیگر

Dr. Tommy Vo serves as Assistant Professor in the Department of Biochemistry & Molecular Biology at Michigan State University, with faculty appointments in the Genetics & Genome Sciences Program, BioMolecular Science Gateway, and Cell & Molecular Biology Program. His research investigates epigenetic mechanisms in Schizosaccharomyces pombe to uncover conserved regulatory principles applicable to higher organisms. His educational background includes a Ph.D. from Cornell University (2016) and B.S. from State University of New York at Binghamton (2010), followed by postdoctoral training at the National Cancer Institute (2016-2021). Research focuses on epigenetic adaptation through heterochromatin dynamics and RNAi pathways, employing genetic, biochemical, and bioinformatic approaches. The lab pioneers humanized yeast models to study human gene functions in tractable systems, bridging fundamental mechanisms with disease relevance. Current projects explore conserved epigenetic factors and their roles in cellular adaptation under stress. Publication trends reveal deep specialization in yeast epigenetics (75% of recent work), with emerging interdisciplinary collaborations in cancer biology and large-scale epidemiology (e.g., Global Vaccine Data Network studies). Core themes emphasize RNA-mediated chromatin regulation and evolutionarily conserved silencing mechanisms. Scientific recognition includes: NIGMS Postdoctoral Research Associate Training (PRAT) Fellowship (2017-2020) Dr. Vo recruits Ph.D. students exclusively through MSU's BioMolecular Sciences umbrella program, with non-degree trainees joining via the Biochemistry Research Trainee Program (domestic) or Visiting Scholars Program (international). Summer research opportunities are available for high school and undergraduate students through direct application by March/April. The lab emphasizes structured mentorship and community engagement in scientific training. The Vo Lab operates from Room 410B (603 Wilson Rd, East Lansing) with active collaborations across MSU's graduate programs, including Reproductive and Developmental Sciences. Current efforts focus on translating yeast epigenetic discoveries to human disease contexts through engineered model systems.

Lulu Jiangمشاهده پروفایل

استادیار

• Neuroscience
• Pharmacology
• Alzheimer's Disease
• +۷ مورد دیگر

Dr. Lulu Jiang is an Assistant Professor in the Department of Neuroscience at the University of Virginia School of Medicine. Her research focuses on the pathophysiology of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and related dementias. Education : MD/PhD from Shandong University and the National Institute of Environmental Health Sciences Key Research Areas : RNA modifications, neuron-glia interactions, iPSC-induced 3D brain organoid modeling, prion-like protein propagation, and genetic/small molecule therapeutics. Her work utilizes cutting-edge technologies such as 3D human brain organoids and single-cell transcriptomics to unravel molecular mechanisms in tauopathies. Publications highlight her contributions to understanding tau protein interactions, RNA epitranscriptomics, and neuroimmunological pathways in disease progression. Labs & Teams : Lead investigator at the Jiang Lab (University of Virginia), affiliated with the Center for Brain Immunology and Glia (BIG). The lab actively recruits new members for research on neurodegenerative disease modeling and therapeutic development.

Furqan M Fazalمشاهده پروفایل

استادیار

• RNA biology
• Mitochondrial gene expression
• Nuclear membrane-less organelles
• +۵ مورد دیگر

Furqan M Fazal is an Assistant Professor and CPRIT Scholar in Cancer Research at Baylor College of Medicine in Houston, Texas. He leads the Fazal Lab within the Department of Biochemistry and Molecular Pharmacology , focusing on RNA subcellular localization mechanisms and their implications in disease. His work bridges biochemical, genomic, and computational approaches to decode RNA organization. Core member of the Therapeutic Innovation Center (THINC) Faculty member at Dan L Duncan Comprehensive Cancer Center Affiliated with Chemical, Physical & Structural Biology and Cancer & Cell Biology Graduate Programs Research Interests center on: Transcriptome-wide RNA subcellular localization Regulation of mitochondrial gene expression RNA localization in nuclear membrane-less organelles Local translation mechanisms and RNA modifications Key Publications reveal trends in: APEX-seq technology for spatial RNA mapping Mitochondrial RNA interactions in disease RNA structural dynamics across compartments Scientific Awards : CPRIT First-time Tenure-track Faculty Award ($2M) NIH K99/R00 Pathway to Independence Award Welch Research Grant Education : Postdoctoral Fellowship (2021-present), PhD (Stanford 2015), MS (Stanford 2010), BA (Amherst College 2008)

Meni Wanunuمشاهده پروفایل

استاد

• Single-Molecule Biophysics
• Nanotechnology
• Biomolecular Engineering
• +۳ مورد دیگر

Meni Wanunu is a Professor of Physics and Bioengineering at Northeastern University, with an affiliation in the Department of Chemical Engineering. His research focuses on developing nanotechnology-based methods for studying biomolecules at the single-molecule level, including nanopore sensors for RNA sequencing and proteomics. His lab bridges fundamental research with translational tools using micro/nanolithography and microfluidic devices. Education: PhD in Chemistry/Materials and Interfaces from the Weizmann Institute of Science (2005). Research Interests: Single-molecule analysis, nanopore technology, electro-optical zero-mode waveguides, and engineered biomolecular sensors. His work integrates computational tools for big data analysis alongside experimental methods. Grants & Awards: NIH grants (e.g., $4.2M for RNA sequencing tools), Northeastern NAI Innovator of the Year Award (2024), and multiple patents (e.g., lipid-free nanopore anchoring). He has been cited in the top 2% of global scientists by Stanford University (2023-2024). Labs/Teams: Wanunu Lab, collaborating with Yale University and industry partners like Oxford Nanopore Technologies.

Stephanie McKayمشاهده پروفایل

دانشیار

• Epigenomics
• Livestock Genetics
• DNA Methylation
• +۲ مورد دیگر

Stephanie McKay is an Associate Professor and Director of Graduate Studies in the Division of Animal Sciences at the University of Missouri. She leads research on epigenetic mechanisms in agricultural species. Education includes a Ph.D. from the University of Alberta, M.S. and B.S. from Texas A&M University. Research Focus: Her laboratory investigates 5-Methylcytosine, 5-Hydroxymethylcytosine and N6-Methyladenosine modifications in livestock. Projects span neuroepigenomics and functional annotation across tissues. Publications: Contributes to international consortia like the Ruminant Telomere-to-Telomere project. Recent work emphasizes multi-omics integration for agricultural genomics.

Ngai Chung Neville Tamمشاهده پروفایل

استادیار

• Urological Diseases
• Prostate Cancer
• Environmental Health
• +۳ مورد دیگر

Ngai Chung Neville Tam, Ph.D., serves as an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences College of Medicine. His research bridges endocrinology, environmental health, and urological disease mechanisms with emphasis on prostate pathologies and lower urinary tract dysfunctions. Education: Ph.D. from the University of Hong Kong Research Interests: Dr. Tam investigates how endocrine status, dietary components, and environmental exposures contribute to urological diseases through estrogen-mediated pathways , epigenetic modifications , and oxidative stress mechanisms . His work spans prostate cancer development, benign prostatic hyperplasia, and transgenerational effects of early-life environmental stressors on fertility and cancer risk. Key methodologies include rodent models, gene expression profiling, and epitranscriptomic analysis to develop prevention strategies for urologic disorders. Publication Trends: Analysis of Dr. Tam's 11 publications (2003-2017) reveals consistent focus on environmental endocrine disruptors (particularly Bisphenol A) and their role in prostate carcinogenesis. His work demonstrates how estrogens induce oxidative/nitrosative stress, disrupt gene networks (HNF4α, MAP3K1), and alter developmental pathways. Recent studies incorporate advanced imaging techniques and organoid models, showing evolution toward translational applications in diagnostic imaging and targeted interventions for prostate diseases. Scientific Awards: No specific awards or fellowships are documented in the provided materials. Advising and Grants: While current students and grant details aren't specified, Dr. Tam's sustained publication record in high-impact journals (Endocrinology, American Journal of Pathology) indicates active NIH or institutional funding supporting his research on environmental impacts on urological health. His collaborative projects with Ho SM and others suggest participation in multi-investigator grants. Labs and Teams: The text indicates collaboration with researchers at UAMS and references work in rodent models (Noble rats, TRAMP mice), but does not specify dedicated laboratory facilities or team composition under Dr. Tam's direct leadership.

Juliet Wongمشاهده پروفایل

استادیار

• Climate Change
• Marine Biology
• Ecology
• +۵ مورد دیگر

Dr. Juliet Wong is an Assistant Professor at Duke University’s Nicholas School of the Environment, based at the Duke University Marine Lab. Her research focuses on understanding how marine invertebrates respond to climate change through physiological and molecular approaches. She earned her Ph.D. from the University of California, Santa Barbara, and completed postdoctoral training at Florida International University as a Distinguished Postdoctoral Scholar and an NSF Postdoctoral Research Fellow. Her work integrates interdisciplinary methods to study organismal responses to environmental changes, emphasizing resilience promotion through collaborations with practitioners, managers, and stakeholders. Research interests include climate change ecology, marine conservation, and the application of epigenetic tools to inform restoration strategies. Key achievements include NSF fellowship awards and leadership in the Wong Lab, which emphasizes student training and partnerships across sectors. Recent activities include presenting at the EPIMAR 2025 symposium and mentoring students like Emma Johnson (PhD) and Lily Zhang (Master’s). Education: Ph.D., University of California, Santa Barbara (2019) Lab Focus: Marine invertebrate resilience, climate adaptation, and interdisciplinary conservation strategies Awards: NSF Postdoctoral Research Fellowship, Distinguished Postdoctoral Scholar Publications span organismal biology, ecology, and evolution, with applied outcomes in resource management and restoration.

Yvonne Böttcherمشاهده پروفایل

استاد

• Obesity Research
• Epigenetics
• RNA Modifications
• +۳ مورد دیگر

Yvonne Böttcher is a Professor and Head of the Department of Clinical Molecular Biology at the University of Oslo, Norway. She leads the "Functional Genetics of Obesity" research group, focusing on epigenetic mechanisms, RNA modifications, and genetic risk variants in obesity and metabolic disorders. Her academic roles include a 20% Research Professor position at Akershus University Hospital. Education & Background: PhD in Biology (2005), University of Leipzig, Germany Master of Science in Biology (2000), Germany Research Interests: Her work explores adipose tissue biology, chromatin accessibility, histone modifications, and RNA methylation in obesity and type 2 diabetes. She investigates the interplay between genetic variants and epigenetic marks, particularly in visceral vs. subcutaneous fat distribution. Awards & Fellowships: 2020 Ferdinand-Bertram-Prize (German Diabetes Society) EFSD/Lilly Research Fellowship (2013) Multiple competitive postdoctoral fellowships (Germany, UK, and Norway) Lab & Team: The group includes researchers like Akin Cayir, Sadia Saeed, and Stina Svensson, focusing on tools like EpiMapper for chromatin analysis. Collaborations span Norway, Germany, and international institutions. Grants & Initiatives: Finalist for the K.G. Jebsen Center for Obesity Research (2021, 2023). Active in precision medicine and obesity research networks (e.g., Nordic Society for Precision Medicine).

Shobbir Hussainمشاهده پروفایل

دانشیار

• Human Genetics
• Molecular Biology
• Neurodevelopmental Disorders
• +۳ مورد دیگر

Shobbir Hussain is an Associate Professor and Senior Lecturer in the Department of Life Sciences at the University of Bath. He holds a PhD in Human Genetics from King’s College London and completed postdoctoral training at the University of Cambridge. His research focuses on understanding how mRNA transcriptome plasticity influences neurodevelopmental disorders and learning difficulties, employing next-generation sequencing and transgenic models for in vivo studies. Education: PhD in Human Genetics, King’s College London Postdoctoral training at the University of Cambridge Research Interests: Dr. Hussain’s work centers on molecular investigations of mRNA transcriptome dynamics, particularly in neurodevelopmental disorders. His laboratory develops and applies advanced sequencing techniques, such as Nanopore sequencing, and utilizes genome-edited models to study biological outcomes. Key areas include RNA methylation mechanisms, epitranscriptomics, and the functional implications of transcriptomic variations. His research has been supported by grants from the Biotechnology and Biological Sciences Research Council, The Wellcome Trust, and The Royal Society. Notable projects include studies on the functions of extra-nuclear splicing regulators, epitranscriptome characterization using catalysis-dependent RIPseq, and the development of FICC-Seq for methyl-5-uridine profiling. Advising and Grants: Dr. Hussain has supervised one documented research student. His grants span from 2015 to 2025, addressing topics such as neuronal connectivity and mRNA methylation patterns. Labs and Teams: His laboratory at the University of Bath specializes in cutting-edge sequencing technologies and in vivo model systems to explore transcriptomic and epigenetic mechanisms underlying neurological conditions.

• Cancer Biology
• Epigenomics
• Gene Regulation
• +۴ مورد دیگر

Suhn Kyong Rhie is an Assistant Professor in the Department of Biochemistry and Molecular Medicine at the Keck School of Medicine, University of Southern California. Her research focuses on understanding gene regulation in cancer and neurodevelopmental diseases through integrative genomic and epigenomic approaches. She leads the Rhie Lab, which employs cutting-edge technologies like ChIP-seq, RNA-seq, and CRISPR/Cas9 to study 3D chromatin structure and transcriptional regulation. Education: She holds a B.S. in Biochemistry (magna cum laude) from UCLA (2007) and a Ph.D. in Genetic, Molecular and Cellular Biology from USC (2013). Her postdoctoral training was conducted under Drs. Peter Laird and Peggy Farnham, focusing on epigenetic mechanisms in cancer. Research Interests: Dr. Rhie investigates how transcription factors and regulatory elements drive disease progression in cancers (e.g., prostate, bladder, colon) and neurodevelopmental disorders. Her work integrates molecular biology, bioinformatics, and high-throughput sequencing to uncover epigenetic and genomic drivers of disease, with a goal of developing therapeutic strategies. Awards: NCCC Cancer Equity Scholar (2023) NCI EIAP Scholar (2022) NCI Career Development Award (2018-2021) Ethel Terry McCoy Award for Excellence in Chemistry and Biochemistry (2007) Key Contributions: Her lab has pioneered methods like Methyl-Micro-C to profile chromatin interactions and DNA methylation. She also leads initiatives in health equity, such as the Florida-California CaRE2 Center, addressing disparities in cancer care. Her research spans collaborative consortia including TCGA, ENCODE, and PsychENCODE.

Nikolay Shirokikhمشاهده پروفایل

پژوهشگر ارشد

• RNA Biology
• Translational Control
• Protein Biosynthesis
• +۲ مورد دیگر

Dr. Nikolay Shirokikh is a Research Fellow at the Australian National University's John Curtin School of Medical Research, where he leads the Shirokikh Group focusing on Protein Biosynthesis and Homeostatic Control. His research examines rapid cellular responses through gene-specific translation analysis using high-throughput RNA/protein methods and computational biology. Research interests include: RNA biology and translational control mechanisms Stress response pathways in cancer and neurological disorders Computational modeling of protein biosynthesis Recent publications (2022-2024) demonstrate a focus on RNA modifications, nanopore sequencing, and machine learning applications in transcriptome analysis. Major themes include RNA modification mapping, translational dynamics under stress, and evolutionary conservation of RNA machinery. Awards: The Gordon Ada Early Career Researcher Award (2016) Supervises PhD students including Shafi Mahmud, Mohammed Muntasir, Agin Ravindran, and Katrina Woodward. Collaborates with the Hannan Group on cancer therapeutics and contributes to the Shine-Dalgarno Centre for RNA Innovation.

• Cancer Genomics
• Bioinformatics
• Computational Biology
• +۸ مورد دیگر

Paul Christopher Boutros is a Professor of Human Genetics and Urology at the University of California, Los Angeles (UCLA), where he also serves as the Acting/Interim Associate Dean in the School of Medicine. He is affiliated with the UCLA Institute of Urologic Oncology and has made significant contributions to cancer genomics, particularly in prostate cancer research. Dr. Boutros holds a PhD in Medical Biophysics from the University of Toronto (2008) and a B.Sc. in Chemistry from the University of Waterloo (2004). He also completed an Executive MBA from the University of Toronto Rotman School of Management (2016). His educational background includes specialized training in mentorship, leadership, and sex and gender in biomedical research. His research focuses on applying computational approaches to cancer genomics, with particular emphasis on prostate cancer. His laboratory integrates machine learning, cloud computing, and advanced statistical methods to analyze genomic, transcriptomic, and proteomic data. Key research areas include cancer heterogeneity, epigenetics, DNA repair mechanisms, and sex differences in cancer biology. His work bridges computational biology with clinical applications, aiming to translate genomic discoveries into improved cancer diagnostics and therapies. Analysis of Dr. Boutros's recent publications reveals a strong focus on prostate cancer genomics, with particular attention to tumor heterogeneity, epigenetic modifications (including N6-methyladenosine), and sex differences in cancer biology. His research increasingly incorporates machine learning approaches to analyze complex genomic datasets and translate findings into clinical applications. The work often involves large-scale collaborative efforts with multiple institutions. Excellence in Postdoctoral Mentoring Award, UCLA, 2023 Outstanding Mentorship Award, BIG Summer Research Program, UCLA, 2023 Bernard and Francine Dorval Prize, Canadian Cancer Society, 2018 Top 25 Peer Reviewer, Journal of the National Cancer Institute, 2019-2020 Early Career Excellence in Graduate Teaching and Mentorship, University of Toronto, 2016 Dr. Boutros has been actively involved in mentoring and training the next generation of scientists, as evidenced by his multiple mentoring awards. His laboratory develops and applies computational pipelines for genomic analysis, including the Metapipeline-DNA framework. His collaborative approach is reflected in numerous multi-institutional projects focused on understanding cancer biology through integrated genomic analyses.

Harley Kornblumمشاهده پروفایل

استاد

• Glioblastoma
• Neural Stem Cells
• Cancer Metabolism
• +۲ مورد دیگر

Harley I. Kornblum is a Professor-in-Residence at UCLA's David Geffen School of Medicine, jointly affiliated with the Departments of Psychiatry and Biobehavioral Sciences and Molecular Medical Pharmacology. His research focuses on glioblastoma tumorigenesis, neural stem cell biology, and cancer metabolism. Key themes include radiation resistance mechanisms, metabolic vulnerabilities in IDH-mutant gliomas, and the role of the tumor microenvironment in recurrence. Kornblum directs NIH-funded projects targeting pathways like mevalonate metabolism and nucleotide synthesis in brain tumors. Recent work explores how endothelial cells and extracellular matrix stiffness influence tumor progression. He mentors trainees in translational neuro-oncology and collaborates extensively across UCLA's neuroscience community.

• Glioblastoma research
• Neuro-oncology
• Brain tumor immunotherapy
• +۵ مورد دیگر

Linda Ming-Huei Liau serves as Professor and Department Chair of Neurosurgery at the University of California Los Angeles, with a secondary appointment as Professor in Molecular and Medical Pharmacology. Her research focuses on brain tumor biology and innovative treatment strategies for malignant gliomas, particularly through immunotherapeutic approaches. Dr. Liau's research interests span neuro-oncology, glioblastoma biology, and cancer immunotherapy. She has pioneered work in dendritic cell vaccination for brain tumors, investigating how these approaches can be enhanced with TLR agonists to polarize immune responses. Her laboratory employs advanced imaging techniques including pH-weighted amine chemical exchange saturation transfer MRI to characterize tumor metabolism and response to therapy. She has made significant contributions to understanding tumor heterogeneity, epigenetic regulation in gliomas, and mechanisms of treatment resistance. Analysis of Dr. Liau's recent publications reveals a strong emphasis on translational neuro-oncology with integration of advanced imaging, molecular profiling, and immunotherapeutic strategies. Her work frequently explores how tumor microenvironment characteristics, including vascular properties and metabolic states, influence treatment response. There's a clear trajectory toward personalized approaches that combine molecular diagnostics with tailored therapeutic interventions for glioma patients. Dr. Liau has been principal investigator on numerous clinical trials, most notably the phase 3 externally controlled cohort trial investigating autologous tumor lysate-loaded dendritic cell vaccination for glioblastoma. Her work has established important benchmarks for immunotherapy approaches in neuro-oncology and continues to shape clinical practice in brain tumor treatment. As Department Chair of Neurosurgery at UCLA, Dr. Liau leads one of the nation's premier neurosurgical programs while maintaining an active research laboratory. Her team employs multi-omic approaches to understand glioma biology and develop novel therapeutic strategies, with particular emphasis on translating laboratory findings to clinical applications for brain tumor patients.

• Transposable Elements
• Genome Plasticity
• Epigenetics
• +۵ مورد دیگر

Dr Jungnam Cho is an Associate Professor in the Department of Biosciences at Durham University, UK. Prior to this role, he served as a Group Leader at the CAS-JIC Centre of Excellence for Plant and Microbial Sciences (2018–2023), jointly affiliated with the John Innes Centre and the Chinese Academy of Sciences. His academic background includes a BSc (2007) and PhD (2013) from Seoul National University, followed by post-doctoral research at the University of Cambridge (2013–2018). Education: Bachelor of Science in Biology, Seoul National University (2007) Doctor of Philosophy in Plant Molecular Biology, Seoul National University (2013) Post-doctoral training at University of Cambridge (2013–2018) Research Interests: Dr Cho’s lab focuses on understanding the biological functions of transposable elements (TEs) in plants, particularly their roles in genome plasticity, epigenetics, and epitranscriptomics. His work challenges the notion of TEs as 'junk DNA' by exploring their contributions to genetic diversity and genome evolution. Using Arabidopsis and rice as primary models, his lab employs a multidisciplinary approach combining genetics, biochemistry, molecular biology, and computational methods to dissect TE regulation mechanisms. Recent studies highlight the lab’s focus on m6A RNA methylation, transposon mobilization under environmental stresses, and leveraging TEs for crop improvement. Articles Trends: His recent publications emphasize the interplay between RNA modifications (e.g., m6A methylation/demethylation) and transposon activity, with a strong focus on plant-specific mechanisms. Collaborations with institutions like Zhejiang University and Fudan University underscore his work’s global impact. Key themes include TE-driven epigenetic reprogramming in bamboo, synthetic retroelement integration, and the role of transposon-derived non-coding RNAs in developmental processes. Scientific Awards: CAS PIFI visiting scholar award (2025) Advising & Grants: Dr Cho currently advises two PhD students: Ben Shone and Seunghui Mun. His lab has secured notable grants including a BBSRC standard research grant and The Great Britain Sasakawa Foundation Grant. Previous notable work includes identifying TEs as microRNA sponges in rice root development and elucidating light-induced histone demethylation in seed germination. Labs & Teams: As head of the Plant Genome Dynamics Lab , Dr Cho leads a team focused on unraveling transposon regulation through innovative techniques like ALE-seq and integrates computational biology with experimental genetics. Collaborators include Professors Chanhong Kim (epigenetic signaling) and Yijing Zhang (rice genomics).